Cargando…
Clinical Ordering Practices of the SARS-CoV-2 Antibody Test at a Large Academic Medical Center
BACKGROUND: The novel severe acute respiratory coronavirus 2 (SARS-CoV-2) that causes coronavirus disease 2019 (COVID-19) originated in December 2019 and has now infected almost 5 million people in the United States. In the spring of 2020, private laboratories and some hospitals began antibody testi...
Autores principales: | Wiencek, Joesph R, Head, Carter L, Sifri, Costi D, Parsons, Andrew S |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7553244/ https://www.ncbi.nlm.nih.gov/pubmed/33072813 http://dx.doi.org/10.1093/ofid/ofaa406 |
Ejemplares similares
-
Patient Outcomes With Prevented vs Negative Clostridioides difficile Tests Using a Computerized Clinical Decision Support Tool
por: Madden, Gregory R, et al.
Publicado: (2020) -
Prevalence of SARS-CoV-2 IgG antibodies in health care workers at a tertiary care academic medical center – An assessment of occupational infection risk
por: Forster, Derek, et al.
Publicado: (2021) -
Propensity-Matched Cost of Clostridioides difficile Infection Overdiagnosis
por: Madden, Gregory R, et al.
Publicado: (2020) -
The Antibody Response to SARS-CoV-2 Infection
por: Hueston, Linda, et al.
Publicado: (2020) -
Feasibility of SARS-CoV-2 Antibody Testing in Remote Outpatient Trials
por: Lofgren, Sarah M, et al.
Publicado: (2021)